The ethanol fraction from the stem of Berberis libanotica inhibits the viability of adult T cell leukemia

被引：0
|
作者：
Esseily, F. [1 ]
El Ezzy, M. [2 ]
Gali-Muhtasib, H. [3 ]
Safi, S. [5 ]
Esseily, J. [5 ]
Diab-Assaf, M. [5 ]
Lampronti, I. [4 ]
Saab, A. [4 ]
机构：
[1] Lebanese Univ, Fac Publ Hlth, Sect 2, Lab Sci Dept, Jdeidet El Metn, Lebanon
[2] Lebanese Univ, Fac Sci 1, Dept Biol, Jdeidet El Metn, Lebanon
[3] Amer Univ Beirut, Dept Biol, Beirut, Lebanon
[4] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy
[5] Lebanese Univ, Fac Sci 2, Dept Biol, Jdeidet El Metn, Lebanon
来源：
MINERVA BIOTECNOLOGICA | 2012年 / 24卷 / 04期
关键词：
Plants; medicinal; Antineoplastic agents; Ethanol; Leukemia-lymphoma; adult T-cell; APOPTOSIS; HTLV-1; PLANTS;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim. In the Mediterranean countries, several described medicinal plants are derived from Lebanon. According to Tohme et al. there are 2597 species in Lebanon. More than fifty two percent are endemic to Lebanon. In this paper we show that the ethanol fraction of the stem of Berberis libanotica is able to inhibit the viability of HTLV-1 positive (HuT-102) and HTLV-1 negative (CEM) cell lines of malignant T-cell leukemia. Methods. After traditional maceration to extract the ethanol fraction from Berberis libanotica stem, the in vitro viability was assayed. Results. The results suggest that Berberis libanotica (a Lebanese medicinal plant) contains a substantial amount of secondary metabolites such as alkaloids powerful in inhibiting the viability of HuT-102 and CEM cell lines. Conclusion. The obtained results demonstrate a novel anticancer property of Berberis libanotica stem extracts, in addition to the previously reported anti-inflammatory activity.
引用
收藏
页码：129 / 133
页数：5
相关论文
共 50 条
  • [21] Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma-Romanian Experience
    Tanase, Alina D.
    Colita, Andrei
    Craciun, Oana G.
    Lipan, Lavinia
    Varady, Zsofia
    Stefan, Laura
    Ranete, Adela
    Pasca, Sergiu
    Bumbea, Horia
    Andreescu, Mihaela
    Popov, Viola
    Bardas, Alexandru
    Coriu, Daniel
    Lupu, Anca Roxana
    Tomuleasa, Ciprian
    Colita, Anca
    Hermine, Olivier
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 11
  • [22] Recent Significance of Allogeneic Hematopoietic Stem Cell Transplantation for Adult T Cell Leukemia/Lymphoma (ATL)
    Tokunaga, Masahito
    Nakano, Nobuaki
    Kubota, Ayumu
    Tokunaga, Mayumi
    Itoyama, Takahiro
    Makino, Torahiko
    Takeuchi, Shogo
    Takatsuka, Yoshifusa
    Utsunomiya, Atae
    BLOOD, 2014, 124 (21)
  • [23] Hematopoietic stem cell transplant outcomes in north american adult t-cell leukemia/lymphoma
    Reef, D.
    DeCastro, A.
    Mustafa, J.
    Khatun, F.
    Lombardo, A.
    Townsend-Nugent, L.
    Wang, Y.
    Shi, Y.
    Gritsman, K.
    Goldfinger, M.
    Shah, N.
    Kornblum, N.
    Shastri, A.
    Mantzaris, I.
    Bachier-Rodriguez, L.
    Verma, A.
    Braunschweig, I.
    Sica, R. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 302 - 303
  • [24] Relapsed adult T cell Leukemia/Lymphoma limited in the skin after allogeneic stem cell transplantation
    Kusumoto, Shigeru
    Ishida, Takashi
    Ito, Asahi
    Inagaki, Atsushi
    Yano, Hiroki
    Ri, Masaki
    Komatsu, Hirokazu
    Iida, Shinsuke
    Inagaki, Hiroshi
    Ueda, Ryuzo
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 652 - 652
  • [25] Improved outcome of adult T-cell leukemia/lymphoma by allogeneic hematopoietic stem cell transplantation
    Utsunomiya, A
    Takatsuka, Y
    Takeuchi, S
    Hanada, S
    Uozumi, K
    Yashiki, S
    Sonoda, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 : S28 - S28
  • [26] Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation
    Yoshimitsu, Makoto
    Tanosaki, Ryuji
    Kato, Koji
    Ishida, Takashi
    Choi, Ilseung
    Takatsuka, Yoshifusa
    Fukuda, Takahiro
    Eto, Tetsuya
    Hidaka, Michihiro
    Uchida, Naoyuki
    Miyamoto, Toshihiro
    Nakashima, Yasuhiro
    Moriuchi, Yukiyoshi
    Nagafuji, Koji
    Miyazaki, Yasuhiko
    Ichinohe, Tatsuo
    Takanashi, Minoko
    Atsuta, Yoshiko
    Utsunomiya, Atae
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 832 - 839
  • [27] FAVORABLE OUTCOME OF REDUCED-INTENSITY STEM CELL TRANSPLANTATION FOR ADULT T-CELL LEUKEMIA
    Iwai, F.
    Kaneko, H.
    Tatsumi, G.
    Matsumoto, T.
    Inada, S.
    Sueki, Y.
    Toyooka, N.
    Fujii, S.
    Nakamura, C.
    Watanabe, M.
    Hirata, H.
    Miura, Y.
    Tsudo, M.
    HAEMATOLOGICA, 2012, 97 : 402 - 402
  • [28] A PROPOSAL FOR SMOLDERING ADULT T-CELL LEUKEMIA - DIVERSITY IN CLINICAL PICTURES OF ADULT T-CELL LEUKEMIA
    YAMAGUCHI, K
    NISHIMURA, H
    KAWANO, F
    KOHROGI, H
    JONO, M
    MIYAMOTO, Y
    TAKATSUKI, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1983, 13 : 189 - 200
  • [29] Targeted therapy of adult T cell leukemia:: From the bench to bedside
    Bazarbachi, A.
    Nasr, R.
    El-Sabban, M.
    El Hajj, H.
    Kfoury, Y.
    Haddad, L.
    Hasegawa, H.
    Hall, W.
    De The, H.
    Hermine, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 112 - 112
  • [30] CHARACTERISTICS OF A LEUKEMIC T-CELL LINE DERIVED FROM ADULT T-CELL LEUKEMIA
    MIYOSHI, I
    KUBONISHI, I
    SUMIDA, M
    YOSHIMOTO, S
    HIRAKI, S
    TSUBOTA, T
    KOBASHI, H
    LAI, M
    TANAKA, T
    KIMURA, I
    MIYAMOTO, K
    SATO, J
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1979, 9 : 485 - 493
12345